| Product Code: ETC7544216 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Gastroesophageal Reflux Disease (GERD) market is experiencing significant growth due to factors such as the increasing prevalence of GERD, changing lifestyle patterns, and rising awareness about the condition among the population. The market is characterized by the availability of various treatment options, including medications, lifestyle modifications, and surgical interventions. Key players in the market are focusing on developing innovative therapies and expanding their product portfolios to cater to the growing demand for effective GERD treatments. Additionally, the market is witnessing a rise in strategic collaborations, partnerships, and mergers and acquisitions among companies to strengthen their market presence. With the rising healthcare expenditure and improving healthcare infrastructure in India, the GERD market is expected to continue its growth trajectory in the coming years.
The India Gastroesophageal Reflux Disease (GERD) market is experiencing significant growth due to a rising prevalence of GERD among the population, lifestyle changes, and increasing awareness about the condition. The market is witnessing a surge in demand for over-the-counter medications, prescription drugs, and minimally invasive surgical procedures for the management of GERD. Additionally, the adoption of advanced diagnostic technologies such as endoscopy and pH monitoring devices is expected to drive market growth. Opportunities exist for pharmaceutical companies to introduce innovative drugs with improved efficacy and fewer side effects, as well as for healthcare providers to offer comprehensive treatment options and patient education programs. Collaborations between pharmaceutical companies and healthcare providers can further enhance market growth by addressing unmet medical needs and improving patient outcomes.
In the India Gastroesophageal Reflux Disease (GERD) market, several challenges are faced, including low awareness about the condition among the general population leading to underdiagnosis and inadequate treatment. Limited access to specialized healthcare facilities and high-quality diagnostic tools in remote areas further restricts appropriate management of GERD. Additionally, the affordability of medications and procedures for GERD treatment can be a significant challenge for a large portion of the population in India. The lack of consistent guidelines for the diagnosis and management of GERD also contributes to variations in treatment approaches among healthcare providers. Overall, addressing these challenges would require efforts to increase awareness, improve access to healthcare services, enhance affordability of treatment options, and establish standardized guidelines for managing GERD effectively in the Indian market.
The India Gastroesophageal Reflux Disease (GERD) market is primarily driven by factors such as the increasing prevalence of GERD cases due to lifestyle changes, unhealthy dietary habits, and rising obesity rates in the country. Additionally, the growing awareness among the population about GERD symptoms and the availability of advanced diagnostic and treatment options are fueling market growth. The healthcare infrastructure improvements, rising healthcare expenditure, and the increasing adoption of minimally invasive surgical procedures for GERD management are also significant drivers of the market. Furthermore, the presence of key players introducing innovative products and technologies in the Indian market is contributing to the overall expansion of the India GERD market.
The Indian government has implemented various policies to address the growing prevalence of Gastroesophageal Reflux Disease (GERD) in the country. These policies focus on improving access to healthcare services, promoting awareness about GERD, and encouraging research and development in the field of gastroenterology. The government has also taken steps to regulate the pharmaceutical industry to ensure the availability of safe and effective medications for treating GERD. Additionally, initiatives such as the National Health Mission aim to strengthen healthcare infrastructure, enhance primary care services, and provide training for healthcare professionals to better manage GERD cases. Overall, the government`s policies are geared towards improving the diagnosis, treatment, and management of GERD in India.
The India Gastroesophageal Reflux Disease (GERD) market is expected to see significant growth in the coming years due to the increasing prevalence of GERD among the Indian population. Factors such as changing dietary habits, rising obesity rates, and a higher incidence of stress-related disorders are contributing to the growing burden of GERD in India. Additionally, advancements in medical technology, increasing healthcare expenditure, and expanding awareness about the condition are expected to drive market growth. Pharmaceutical companies are likely to focus on developing innovative treatment options and expanding their product portfolios to cater to the growing demand for GERD medications in India. Overall, the India GERD market is poised for expansion, presenting opportunities for market players to capitalize on the increasing healthcare needs of the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Gastroesophageal Reflux Disease Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Gastroesophageal Reflux Disease Market Revenues & Volume, 2021 & 2031F |
3.3 India Gastroesophageal Reflux Disease Market - Industry Life Cycle |
3.4 India Gastroesophageal Reflux Disease Market - Porter's Five Forces |
3.5 India Gastroesophageal Reflux Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Gastroesophageal Reflux Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Gastroesophageal Reflux Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastroesophageal reflux disease (GERD) in India due to changing lifestyles and dietary habits |
4.2.2 Growing awareness about GERD among healthcare professionals and patients leading to early diagnosis and treatment |
4.2.3 Adoption of advanced diagnostic technologies and treatment options in the healthcare sector in India |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and diagnostic services in rural areas of India |
4.3.2 High treatment costs associated with managing GERD, impacting affordability for a large section of the population |
4.3.3 Lack of standardized treatment guidelines and variability in healthcare quality across different regions in India |
5 India Gastroesophageal Reflux Disease Market Trends |
6 India Gastroesophageal Reflux Disease Market, By Types |
6.1 India Gastroesophageal Reflux Disease Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Antacids, 2021- 2031F |
6.1.4 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Proton Pump Inhibitors, 2021- 2031F |
6.1.5 India Gastroesophageal Reflux Disease Market Revenues & Volume, By H2 Receptor Blocker, 2021- 2031F |
6.1.6 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Pro Kinetic Agents, 2021- 2031F |
6.1.7 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Dopamine Receptor Antagonist, 2021- 2031F |
6.1.8 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Endocinch, 2021- 2031F |
6.2 India Gastroesophageal Reflux Disease Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.2.4 India Gastroesophageal Reflux Disease Market Revenues & Volume, By General Stores, 2021- 2031F |
6.2.5 India Gastroesophageal Reflux Disease Market Revenues & Volume, By Supermarkets, 2021- 2031F |
7 India Gastroesophageal Reflux Disease Market Import-Export Trade Statistics |
7.1 India Gastroesophageal Reflux Disease Market Export to Major Countries |
7.2 India Gastroesophageal Reflux Disease Market Imports from Major Countries |
8 India Gastroesophageal Reflux Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of GERD |
8.2 Percentage of patients receiving appropriate treatment for GERD as per clinical guidelines |
8.3 Number of healthcare facilities offering specialized care for GERD |
8.4 Patient satisfaction with GERD treatment outcomes |
8.5 Rate of adoption of minimally invasive surgical procedures for GERD management |
9 India Gastroesophageal Reflux Disease Market - Opportunity Assessment |
9.1 India Gastroesophageal Reflux Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Gastroesophageal Reflux Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Gastroesophageal Reflux Disease Market - Competitive Landscape |
10.1 India Gastroesophageal Reflux Disease Market Revenue Share, By Companies, 2024 |
10.2 India Gastroesophageal Reflux Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |